Funder
Royal College of Pathologists of Australasia
Department of Health | National Health and Medical Research Council
Royal Adelaide Hospital
National Breast Cancer Foundation
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Kohler, B. A. et al. Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state. J. Natl Cancer Inst. 107, djv048 (2015). E-pub ahead of print 2015/04/01.
2. Howlader, N., Cronin, K. A., Kurian, A. W. & Andridge, R. Differences in breast cancer survival by molecular subtypes in the United States. Cancer Epidemiol. Biomark. & Prev. a Publ. Am. Assoc. Cancer Res. cosponsored Am. Soc. Prev. Oncol. 27, 619–626 (2018). E-pub ahead of print 2018/03/30.
3. Horwitz, K. B. & McGuire, W. L. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J. Biol. Chem. 253, 2223–2228 (1978). E-pub ahead of print 1978/04/10.
4. Snell C. E., et al. Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen. J. Clin. Pathol. 70, 954–960 (2017). E-pub ahead of print 2017/04/19.
5. Stendahl, M. et al. High progesterone receptor expression correlates to the effect of adjuvant tamoxifen in premenopausal breast cancer patients. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 12, 4614–4618 (2006). E-pub ahead of print 2006/08/11.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献